×
About 5,790 results

ALLMedicine™ Hypokalemia Center

Research & Reviews  1,407 results

Focal Segmental Glomerulosclerosis Treatment & Management
http://emedicine.medscape.com/article/245915-treatment

Aug 9th, 2022 - Approach Considerations Treatment of focal segmental glomerulosclerosis (FSGS) can be divided into nonspecific and specific treatment. In patients with primary or secondary FSGS (non-nephrotic or nephrotic) and proteinuria, the initial approach co...

A noninvasive scoring model for the differential diagnosis of ACTH-dependent Cushing's ...
https://doi.org/10.1007/s12020-022-03081-0
Endocrine Lyu X, Zhang D et. al.

Aug 5th, 2022 - The differential diagnosis of ACTH-dependent Cushing's disease (CS) is challenging. The gold standard approach bilateral inferior petrosal sinus sampling (BIPSS) is expensive and invasive, while other noninvasive tests, like the high-dose dexameth...

Preoperative hypokalemia can increase complications after colorectal cancer surgery: a ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347170
BMC Cancer; Zhang B, Liu XY et. al.

Aug 4th, 2022 - Whether hypokalemia can affect the short-term outcomes of CRC patients after radical surgery remains unclear. The purpose of this study was to investigate the impact of preoperative hypokalemia on the short-term outcomes for colorectal cancer (CRC...

Diagnostic and therapeutic approach to hypernatremia.
https://doi.org/10.1515/dx-2022-0034
Diagnosis (Berlin, Germany); Ilardi A

Aug 3rd, 2022 - Hypernatremia occurs when the plasma sodium concentration is greater than 145 mmol/L. Depending on the duration, hypernatremia can be differentiated into acute and chronic. According to severity: mild, moderate and threatening hypernatremia. Final...

A novel CLCNKB variant in a Chinese family with classic Bartter syndrome and prenatal g...
https://doi.org/10.1002/mgg3.2027
Molecular Genetics & Genomic Medicine; Zhao Q, Xiang Q et. al.

Aug 2nd, 2022 - Type III Bartter syndrome (BS), often known as classic Bartter syndrome is caused by variants in CLCNKB gene, which encoding the basolateral chloride channel protein ClC-Kb, and is characterized by renal salt wasting, hypokalemia, metabolic alkalo...

see more →

Guidelines  1 results

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an end...
https://doi.org/10.1210/jc.2008-0104
The Journal of Clinical Endocrinology and Metabolism; Funder JW, Carey RM et. al.

Jun 17th, 2008 - Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, si...

see more →

Drugs  574 results see all →

Clinicaltrials.gov  80 results

Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAE
https://clinicaltrials.gov/ct2/show/NCT05188872

Jul 28th, 2022 - Primary aldosteronism: Hypertension is divided into primary hypertension and secondary hypertension. Secondary hypertension refers to hypertension with clear etiology. When the etiology is identified and effectively removed or controlled, hyperten...

Diuretic Tuner Clinical Decision Support
https://clinicaltrials.gov/ct2/show/NCT04759274

Jul 26th, 2022 - Study Population: 30 subjects with signs of hypervolemia and either nephrotic syndrome or chronic kidney disease 4 to 5. Study Intervention: This is a nonrandomized, uncontrolled trial. The Diuretic Tuner mobile device application will be deployed...

Fluconazole in Hypercalciuric Patients With Increased 1,25(OH)2D Levels
https://clinicaltrials.gov/ct2/show/NCT04495608

Jul 6th, 2022 - Hypercalciuria is one of the most frequent metabolic disorders associated with nephrolithiasis and/or nephrocalcinosis leading to Chronic Kidney Disease (CKD) and bone complications in adults. Hypercalciuria can be secondary to increased intestina...

Comparison of a Low Dose to a Standard Dose of Insulin in Adult DKA in ICU to Reduce Metabolic Complications
https://clinicaltrials.gov/ct2/show/NCT05443802

Jul 5th, 2022 - Diabetic ketoacidosis (DKA), a frequent complication of diabetes, is the consequence of a profound insulin deficiency responsible for osmotic polyuria which leads to major losses of water, sodium and potassium as well as the generation of metaboli...

A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China
https://clinicaltrials.gov/ct2/show/NCT05271266

Jun 15th, 2022 - Background/Rationale: Hyperkalaemia (HK) is a common electrolyte disturbance in clinical practice, defined as serum potassium (sK) beyond the normal range. The cut-off value for HK diagnosis is 5.0 mmol/L in most international guidelines[1, 2]. HK...

see more →

News  254 results

A Man With Hypokalemia, Sleep Apnea, and Resistant Hypertension
https://www.medscape.com/viewarticle/976833

Jul 20th, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Potassium Abnormalities Boost Hospital Visits for Kidney Disease
https://www.medscape.com/viewarticle/972652

Apr 25th, 2022 - Patients with advanced chronic kidney disease (CKD) are at higher risk of hospitalization or requiring an emergency room (ER) visit in the short-term if they have abnormal potassium levels, a nationally representative cohort of US veterans with ad...

Pegcetacoplan Improves Efficacy in Complement Inhibitor–Naïve Paroxysmal Nocturnal Hemoglobinuria
https://www.onclive.com/view/pegcetacoplan-improves-efficacy-in-complement-inhibitor-na-ve-paroxysmal-nocturnal-hemoglobinuria

Apr 9th, 2022 - Pegcetacoplan (Empaveli) treatment was associated with hemoglobin stabilization and normalization, as well as a superior change from baseline in hemoglobin levels, which showed a meaningful correction of anemia, in patients with complement inhibit...

Avapritinib Approved in Europe for Advanced Systemic Mastocytosis
https://www.onclive.com/view/avapritinib-approved-in-europe-for-advanced-systemic-mastocytosis

Mar 25th, 2022 - The European Commission has expanded the current indication for avapritinib (Ayvakyt) to include use as a single agent in adult patients with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematologic neoplasm, or mast ...

Pembrolizumab Plus Gemcitabine/Hypofractionated Radiotherapy Demonstrates Promising Efficacy in Muscle-Invasive Bladder Cancer
https://www.onclive.com/view/pembrolizumab-plus-gemcitabine-hypofractionated-radiotherapy-demonstrates-promising-efficacy-in-muscle-invasive-bladder-cancer

Mar 1st, 2022 - Pembrolizumab (Keytruda) in combination with gemcitabine and concurrent hypofractionated radiotherapy (RT) appears to be a promising and efficacious, bladder-sparing regimen for patients with muscle-invasive bladder cancer (MIBC), according to fin...

see more →